[Frontiers in Bioscience 2, d482-500, October 1, 1997]

	[Frontiers in Bioscience 2, d482-500, October 1, 1997] Reprints PubMed CAVEAT LECTOR
	PROSTAGLANDINS AND CANCER Susan M. Fischer The University of Texas M. D. Anderson Cancer Center, Science Park-Research Division, Smithville, TX 78957 Received 9/3/97 Accepted 9/23/97 7. ACKNOWLEDGEMENTS The author wishes to acknowledge, and to apologize for, the many investigations that are not directly referenced here. The author is a Professor of Carcinogenesis at The University of Texas M.D. Anderson, Science Park-Research Division and has been supported by grants from the NIH on the topic of prostaglandins and cancer, particularly, CA-34443.

[Frontiers in Bioscience 2, d482-500, October 1, 1997]
Reprints
PubMed
CAVEAT LECTOR

PROSTAGLANDINS AND CANCER

Susan M. Fischer

The University of Texas M. D. Anderson Cancer Center, Science Park-Research Division, Smithville, TX 78957

Received 9/3/97 Accepted 9/23/97

7. ACKNOWLEDGEMENTS

The author wishes to acknowledge, and to apologize for, the many investigations that are not directly referenced here. The author is a Professor of Carcinogenesis at The University of Texas M.D. Anderson, Science Park-Research Division and has been supported by grants from the NIH on the topic of prostaglandins and cancer, particularly, CA-34443.